'Egfr signaling' presentation slideshows

Adenocarcinoma of the lung: a molecular perspective

1.63k views • 29 slides

Drosophila

499 views • 27 slides

Drosophila

294 views • 27 slides

Aiming at the Wrong Target? Discussion of Abstracts CRA3507 (Alberts) and 3508 (Goldberg)

Aiming at the Wrong Target? Discussion of Abstracts CRA3507 (Alberts) and 3508 (Goldberg). Louis M. Weiner, MD Lombardi Comprehensive Cancer Center Georgetown University Medical Center. Potential Conflicts Relevant to this Presentation. Consultant, Stock Options Merrimack Pharmaceuticals

379 views • 22 slides

Janjigian YY et al. Proc ASCO 2011;Abstract 7525.

Activity and Tolerability of Afatinib (BIBW 2992) and Cetuximab in NSCLC Patients with Acquired Resistance to Erlotinib or Gefitinib. Janjigian YY et al. Proc ASCO 2011;Abstract 7525. Introduction.

213 views • 8 slides